• Publications
  • Influence
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.
CONTEXT Recent data regarding the consequences of untreated human immunodeficiency virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and antiretroviral-experiencedExpand
  • 2,291
  • 41
  • PDF
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
BACKGROUND Chronic hepatitis C virus (HCV) infection is a cause of major complications in persons who are also infected with the human immunodeficiency virus (HIV). However, the treatment of HCVExpand
  • 867
  • 37
  • PDF
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
OBJECTIVE New information warrants updated recommendations for the 4 central issues in antiretroviral therapy: when to start, what drugs to start with, when to change, and what to change to. TheseExpand
  • 748
  • 34
  • PDF
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
CONTEXT The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral-naive and -experienced patients warrantExpand
  • 917
  • 32
  • PDF
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
CONTEXT Guidelines for antiretroviral therapy are important for clinicians worldwide given the complexity of the field and the varied clinical situations in which these agents are used. TheExpand
  • 628
  • 24
  • PDF
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
CONTEXT New trial data and drug regimens that have become available in the last 2 years warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infectedExpand
  • 648
  • 24
  • PDF
HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group
Abstract:HIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, currentExpand
  • 375
  • 20
  • PDF
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.
IMPORTANCE New data and antiretroviral regimens expand treatment choices in resource-rich settings and warrant an update of recommendations to treat adults infected with human immunodeficiency virusExpand
  • 369
  • 20
  • PDF
Antiretroviral therapy and management of HIV infection
Antiretroviral therapy of HIV infection has changed a uniformly fatal into a potentially chronic disease. There are now 17 drugs in common use for HIV treatment. Patients who can access and adhere toExpand
  • 359
  • 17
  • PDF
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
CONTEXT Guidelines for antiretroviral therapy are important for clinicians worldwide given the complexity of the field and the varied clinical situations in which these agents are used. TheExpand
  • 808
  • 16